RCAP
MYOV

Resolute Capital Asset Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

Resolute Capital Asset Partners’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$666K – 56
2022
Q1 		$666K Buy
+50,000
New +$670K 0.43% 38

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Resolute Capital Asset Partners's MYOV Position: Q2 2022 in Review

Resolute Capital Asset Partners sold out of Myovant Sciences Ltd. (MYOV) in Q2 2022, closing a stake of 50,000 shares — an estimated $666K sold.

Resolute Capital Asset Partners first reported a position in MYOV in Q1 2022 and held it in 1 quarter. The position peaked at $666K in Q1 2022. 91 funds tracked by Wall St. Rank hold MYOV as of Q2 2022.

  • Resolute Capital Asset Partners reported no remaining Myovant Sciences Ltd. position as of Q2 2022 after selling out during the quarter.
  • Resolute Capital Asset Partners sold 50,000 Myovant Sciences Ltd. shares in Q2 2022, an estimated $666K.
  • Resolute Capital Asset Partners first reported a position in Myovant Sciences Ltd. in Q1 2022 and held it in 1 quarter.
  • Resolute Capital Asset Partners's Myovant Sciences Ltd. position peaked at $666K in Q1 2022.
  • 91 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2022.

Based on Resolute Capital Asset Partners's 13F filing for Q2 2022, filed 12 Aug 2022.